Stockscreener 앱 받기
44.12
3.30%
1.41
Medline Inc 주식(MDLN)의 최신 뉴스
In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business
Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry
Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus
Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - TradingView — Track All Markets
Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging
Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette
Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg.com
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com
Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga
Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance
Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters
TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medline initiated with a Buy at BTIG - TipRanks
Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com
BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com
JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target - marketscreener.com
William Blair initiates Medline stock with Outperform rating By Investing.com - Investing.com South Africa
BTIG initiates coverage on Medline stock with Buy rating, $50 target - Investing.com Nigeria
Wells Fargo initiates coverage on Medline stock with Equal Weight rating - Investing.com Nigeria
BofA Securities initiates Medline stock with Buy rating, $50 price target - Investing.com Nigeria
Analysts initiate Medline with bullish ratings after blockbuster IPO By Reuters - Investing.com
Medline initiated with an Outperform at Mizuho - TipRanks
RBC Initiates Medline at Outperform With $47 Price Target - marketscreener.com
Medline (MDLN) Valuation Check As Shares Trade Near DCF Fair Value And Sector P/E Discount - Sahm
William Blair initiates Medline stock with Outperform rating - Investing.com
Medline: Vertically Integrated Growth Leader With Prime Vendor Advantage Supporting Buy-Rated Risk/Reward - TipRanks
Medline: Durable Moat, Secular Tailwinds, and Attractive Valuation Support Buy Rating - TipRanks
Medline: Prime Vendor Flywheel, Durable Growth, and Supportive Valuation Underscore Overweight/Buy Rating - TipRanks
Mizuho initiates Medline stock with Outperform rating, $48 price target By Investing.com - Investing.com India
Mizuho initiates Medline stock with Outperform rating, $48 price target - Investing.com
Analysts start coverage on Medline with bullish ratings - TradingView — Track All Markets
Baird initiates coverage on Medline stock with Outperform rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Medline stock with Overweight rating, $50 price target By Investing.com - Investing.com Nigeria
Rothschild Redburn initiates Medline stock with Neutral rating, $42 target By Investing.com - Investing.com Nigeria
Stifel initiates coverage on Medline stock with Buy rating, $46 target - Investing.com Nigeria
Truist Securities initiates Medline stock with Buy rating, $52 price target - Investing.com India
BMO Capital initiates Medline stock with Outperform rating, $45 target - Investing.com
UBS initiates Medline stock with Buy rating, $48 price target - Investing.com
Jefferies initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com Australia
Jefferies initiates coverage on Medline stock with Buy rating, $50 target - Investing.com Nigeria
Morgan Stanley initiates Medline stock with Overweight rating, $48 target - Investing.com
Medline stock initiated with Outperform rating by Evercore ISI - Investing.com South Africa
Baird initiates coverage on Medline stock with Outperform rating - Investing.com
Medline stock initiated with Outperform rating by Evercore ISI By Investing.com - Investing.com Nigeria
Leerink Partners initiates Medline stock coverage with Outperform rating By Investing.com - Investing.com South Africa
Piper Sandler initiates Medline stock with Overweight rating, $50 target By Investing.com - Investing.com Nigeria
RBC Capital initiates coverage on Medline stock with Outperform rating - Investing.com
1.20%
0.07%
자본화:
|
볼륨(24시간):